PCI Biotech Holding ASA
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway. Show More...
-
Website https://www.pcibiotech.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.66 NOK
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share NOK -1.26 -1.07 -1.96 -2.14 -3.22 -2.13 -2.01 -1.76 -1.25 -2.38 -1.65 Dividends NOK Payout Ratio % * Shares Mil 12.0 14.0 14.0 14.0 12.0 15.0 16.0 25.0 28.0 38.0 38.0 Book Value Per Share * NOK 8.5 7.5 5.98 4.01 1.47 2.44 1.22 2.08 0.4 7.48 6.98 Free Cash Flow Per Share * NOK -1.23 -0.99 -1.7 -2.14 -2.51 -1.63 -1.58 -1.43 -1.22 -1.67 Return on Assets % -17.86 -12.81 -28.32 -42.17 -98.03 -83.15 -81.69 -106.0 -16.74 -27.77 -19.79 Financial Leverage (Average) 1.09 1.08 1.12 1.22 2.24 1.27 1.71 1.4 1.05 1.11 1.08 Return on Equity % -19.84 -13.89 -31.14 -48.82 -136.5 -119.56 -112.2 -155.99 -18.22 -29.84 -21.25 Return on Invested Capital % -19.16 -13.59 -34.0 -51.86 -139.6 -122.81 -113.74 -158.45 -18.55 -30.36 -30.49 Interest Coverage -296.26 -174.39 13.94 Current Ratio 17.33 17.19 10.19 5.72 1.81 4.65 2.4 4.01 21.01 11.2 14.19 Quick Ratio 17.33 17.19 10.14 5.01 1.35 4.02 1.44 3.44 20.51 10.56 14.19 Debt/Equity 0.02 0.02